Skip to main content
Erschienen in: Angiogenesis 4/2018

28.06.2018 | Original Paper

Heparin impairs angiogenic signaling and compensatory lung growth after left pneumonectomy

verfasst von: Duy T. Dao, Lorenzo Anez-Bustillos, Jared Ourieff, Amy Pan, Paul D. Mitchell, Hiroko Kishikawa, Gillian L. Fell, Meredith A. Baker, Randolph S. Watnick, Hong Chen, Thomas E. Hamilton, Michael S. Rogers, Diane R. Bielenberg, Mark Puder

Erschienen in: Angiogenesis | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Children with hypoplastic lung diseases, such as congenital diaphragmatic hernia, can require life support via extracorporeal membrane oxygenation and systemic anticoagulation, usually in the form of heparin. The role of heparin in angiogenesis and organ growth is inconclusive, with conflicting data reported in the literature. This study aimed to investigate the effects of heparin on lung growth in a model of compensatory lung growth (CLG). Compared to the absence of heparin, treatment with heparin decreased the vascular endothelial growth factor (VEGF)-mediated activation of VEGFR2 and mitogenic effect on human lung microvascular endothelial cells in vitro. Compared to non-heparinized controls, heparinized mice demonstrated impaired pulmonary mechanics, decreased respiratory volumes and flows, and reduced activity levels after left pneumonectomy. They also had lower lung volume, pulmonary septal surface area and alveolar density on morphometric analyses. Lungs of heparinized mice displayed decreased phosphorylation of VEGFR2 compared to the control group, with consequential downstream reduction in markers of cellular proliferation and survival. The use of bivalirudin, an alternative anticoagulant that does not interact with VEGF, preserved lung growth and pulmonary mechanics. These results demonstrated that heparin impairs CLG by reducing VEGFR2 activation. These findings raise concern for the clinical use of heparin in the setting of organ growth or regeneration.
Literatur
2.
Zurück zum Zitat Onishi A, St Ange K, Dordick JS, Linhardt RJ (2016) Heparin and anticoagulation. Front Biosci 21:1372–1392CrossRef Onishi A, St Ange K, Dordick JS, Linhardt RJ (2016) Heparin and anticoagulation. Front Biosci 21:1372–1392CrossRef
8.
Zurück zum Zitat Coltrini D, Rusnati M, Zoppetti G et al (1994) Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor. Biochem J 303:583–590CrossRef Coltrini D, Rusnati M, Zoppetti G et al (1994) Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor. Biochem J 303:583–590CrossRef
10.
Zurück zum Zitat Norrby K (2000) 2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis. Int J Exp Pathol 81:191–198CrossRef Norrby K (2000) 2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis. Int J Exp Pathol 81:191–198CrossRef
13.
Zurück zum Zitat Koyanagi S, Tanigawa N, Nakagawa H et al (2003) Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65:173–179CrossRef Koyanagi S, Tanigawa N, Nakagawa H et al (2003) Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65:173–179CrossRef
21.
Zurück zum Zitat Scherle W (1970) A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26:57–60 Scherle W (1970) A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26:57–60
24.
Zurück zum Zitat Weibel ER, Gomez DM (1962) A principle for counting tissue structures on random sections. J Appl Physiol 17:343–348CrossRef Weibel ER, Gomez DM (1962) A principle for counting tissue structures on random sections. J Appl Physiol 17:343–348CrossRef
26.
Zurück zum Zitat Salazar E, Knowles JH (1964) An analysis of pressure-volume characteristics of the lungs. J Appl Physiol 19:97–104CrossRef Salazar E, Knowles JH (1964) An analysis of pressure-volume characteristics of the lungs. J Appl Physiol 19:97–104CrossRef
27.
Zurück zum Zitat Collen A, Smorenburg SM, Peters E et al (2000) Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res 60:6196–6200PubMed Collen A, Smorenburg SM, Peters E et al (2000) Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res 60:6196–6200PubMed
33.
Zurück zum Zitat East MA, Landis DI, Thompson MA, Annex BH (2003) Effect of single dose of intravenous heparin on plasma levels of angiogenic growth factors. Am J Cardiol 91:1234–1236CrossRef East MA, Landis DI, Thompson MA, Annex BH (2003) Effect of single dose of intravenous heparin on plasma levels of angiogenic growth factors. Am J Cardiol 91:1234–1236CrossRef
38.
Zurück zum Zitat Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88:435–437CrossRef Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88:435–437CrossRef
Metadaten
Titel
Heparin impairs angiogenic signaling and compensatory lung growth after left pneumonectomy
verfasst von
Duy T. Dao
Lorenzo Anez-Bustillos
Jared Ourieff
Amy Pan
Paul D. Mitchell
Hiroko Kishikawa
Gillian L. Fell
Meredith A. Baker
Randolph S. Watnick
Hong Chen
Thomas E. Hamilton
Michael S. Rogers
Diane R. Bielenberg
Mark Puder
Publikationsdatum
28.06.2018
Verlag
Springer Netherlands
Erschienen in
Angiogenesis / Ausgabe 4/2018
Print ISSN: 0969-6970
Elektronische ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-018-9628-3

Weitere Artikel der Ausgabe 4/2018

Angiogenesis 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.